To test whether the increased RalA GTPase activity contributes to cell malignant phenotypes in CML cells, we constructed a RalA expression plasmid for RalA overexpression studies. This evidence concerns the gene RALA and chronic myelogenous leukemia, BCR-ABL1 positive.